Product Information
ACETAMINOPHEN 650 MG SUPPOS is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3395 per EA under NDC 45802073000. Its NADAC has been published 460 times since Sep 6, 2017.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
650 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802073000
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA070608On Market Since
10/28/2010
Price Statistics
The NADAC for ACETAMINOPHEN 650 MG SUPPOS has been published 460 times since Sep 6, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3395 per EA |
|---|---|
| All-time high | $0.3731 (Mar 14, 2018) |
| All-time low | $0.2796 (Dec 20, 2017) |
| 52-week high | $0.3472 |
| 52-week low | $0.3340 |
| Median price | $0.3389 |
| Average price | $0.3352 |
| Largest weekly change | +28.1% (Jan 17, 2018) |
| Weeks tracked | 460 |
| Tracking since | Sep 6, 2017 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 650 MG SUPPOS?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 650 MG SUPPOS, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3395 per EA (NDC 45802073000), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN 650 MG SUPPOS changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 650 MG SUPPOS has held within roughly two percent of its current level. It has been tracked across 460 weekly CMS publications since Sep 6, 2017.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 650 MG SUPPOS?
Since Sep 6, 2017, the NADAC for ACETAMINOPHEN 650 MG SUPPOS has ranged from a low of $0.2796 (Dec 20, 2017) to a high of $0.3731 (Mar 14, 2018), with a median of $0.3389 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 650 MG SUPPOS?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC ARTHRITIS PAIN ER 650 MG, is $0.0599 per EA — about 82% below ACETAMINOPHEN 650 MG SUPPOS.
Who manufactures ACETAMINOPHEN 650 MG SUPPOS?
ACETAMINOPHEN 650 MG SUPPOS (NDC 45802073000) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification